{
    "data": [
        {
            "id": "urn:summary_document_report:quartr.com:2935523:0",
            "title": "WD: Strong transaction growth offset by asset impairments and loan losses, but outlook remains positive",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Transaction volume surged 36% in Q4 and 37% for the year, but net income and EPS declined sharply due to asset impairments and indemnified loan losses. Despite these headwinds, recurring revenues from a growing servicing portfolio and a robust capital markets pipeline position the company for growth in 2026.</span></p><p class=\"\"><span>Original document: </span><a class=\"link-zw5jRdec\" href=\"https://www.tradingview.com/accounts/signin?next=https%3A%2F%2Fnews-mediator.tradingview.com%2Fdoc-screener%2Fv1%2Ffiles%2Furn%3Areport%3Aquartr.com%3A2935523-b46e336a069a5fe687fbcbf9f2ced8ba\" target=\"_blank\">Walker &amp; Dunlop, Inc [WD] SEC 8-K Current Report — Feb. 26 2026</a></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_report:quartr.com:2935523:0-wd-strong-transaction-growth-offset-by-asset-impairments-and-loan-losses-but-outlook-remains-positive/",
            "pub_date": "2026-02-26 19:05:30",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:summary_document_report:quartr.com:2935528:0",
            "title": "ECVT: Strong 2025 growth, major divestiture, and robust 2026 outlook with enhanced liquidity",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Sales and Adjusted EBITDA grew strongly in 2025, driven by higher sulfuric acid volumes and pricing, while the divestiture of a major segment enabled significant debt reduction and share repurchases. 2026 guidance anticipates continued growth and robust cash generation.</span></p><p class=\"\"><span>Original document: </span><a class=\"link-zw5jRdec\" href=\"https://www.tradingview.com/accounts/signin?next=https%3A%2F%2Fnews-mediator.tradingview.com%2Fdoc-screener%2Fv1%2Ffiles%2Furn%3Areport%3Aquartr.com%3A2935528-160ad6994fb802c7b19db6788e13e67d\" target=\"_blank\">Ecovyst Inc. [ECVT] SEC 8-K Current Report — Feb. 26 2026</a></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_report:quartr.com:2935528:0-ecvt-strong-2025-growth-major-divestiture-and-robust-2026-outlook-with-enhanced-liquidity/",
            "pub_date": "2026-02-26 19:05:33",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026-02-26:newsml_RSZ5622Ua:0",
            "title": "REG - BNP Paribas London Schroders PLC - Form 8.5 (EPT/RI) Schroders BNP Paribas Group SA",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><span>RNS Number : 5622U  BNP Paribas London  26 February 2026   </span><p class=\"\"><span>FORM 8.5 (EPT/RI)</span></p><p class=\"\"><span>PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY</span></p><p class=\"\"><span>Rule 8.5 of the Takeover Code (the \"Code\")</span></p><p class=\"\"><span>1.         KEY INFORMATION</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>(a) Name of exempt principal trader:</span></p></td><td><p class=\"\"><span>BNP Paribas SA</span></p></td></tr><tr><td><p class=\"\"><span>(b) Name of offeror/offeree in relation to whose relevant securities this form relates:</span></p><p class=\"\"><span>     Use a separate form for each offeror/offeree</span></p></td><td><p class=\"\"><span>Schroders Plc</span></p></td></tr><tr><td><p class=\"\"><span>(c) Name of the party to the offer with which exempt principal trader is connected:</span></p></td><td><p class=\"\"><span>Connected to offeree Pantheon, LLC</span></p></td></tr><tr><td><p class=\"\"><span>(d) Date dealing undertaken:</span></p></td><td><p class=\"\"><span>25/02/2026</span></p></td></tr><tr><td><p class=\"\"><span>(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?</span></p><p class=\"\"><span>     If it is a cash offer or possible cash offer, state \"N/A\"</span></p></td><td><p class=\"\"><span>No</span></p><p class=\"\"><span>If YES, specify which:</span></p></td></tr></tbody></table></div><p class=\"\"><span>2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER</span></p><p class=\"\"><span>Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.</span></p><p class=\"\"><span>The currency of all prices and other monetary amounts should be stated.</span></p><p class=\"\"><span>(a)        Purchases and sales</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Class of relevant security</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Purchases/ sales</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Total number of securities</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Highest price per unit paid/received</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Lowest price per unit paid/received</span></p></li></ul><p class=\"\"><span>(b)        Cash-settled derivative transactions</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>Class of relevant security</span></p></td><td><p class=\"\"><span>Product description</span></p><p class=\"\"><span>e.g. CFD</span></p></td><td><p class=\"\"><span>Nature of dealing</span></p><p class=\"\"><span>e.g. opening/closing a long/short position, increasing/reducing a long/short position</span></p></td><td><p class=\"\"><span>Number of reference securities</span></p></td><td><p class=\"\"><span>Price per unit</span></p></td></tr><tr><td><p class=\"\"><span>GB00BP9LHF23</span></p></td><td><p class=\"\"><span>Contract for Difference</span></p></td><td><p class=\"\"><span>Opening Long Position</span></p></td><td><p class=\"\"><span>1,787</span></p></td><td><p class=\"\"><span>5.8600 USD</span></p></td></tr><tr><td><p class=\"\"><span>GB00BP9LHF23</span></p></td><td><p class=\"\"><span>Contract for Difference</span></p></td><td><p class=\"\"><span>Opening Long Position</span></p></td><td><p class=\"\"><span>3,414</span></p></td><td><p class=\"\"><span>5.8600 GBP</span></p></td></tr><tr><td><p class=\"\"><span>GB00BP9LHF23</span></p></td><td><p class=\"\"><span>Contract for Difference</span></p></td><td><p class=\"\"><span>Opening Short Position</span></p></td><td><p class=\"\"><span>-331</span></p></td><td><p class=\"\"><span>5.8600 GBP</span></p></td></tr><tr><td><p class=\"\"><span>GB00BP9LHF23</span></p></td><td><p class=\"\"><span>Contract for Difference</span></p></td><td><p class=\"\"><span>Opening Short Position</span></p></td><td><p class=\"\"><span>-525,000</span></p></td><td><p class=\"\"><span>5.8600 GBP</span></p></td></tr><tr><td><p class=\"\"><span>GB00BP9LHF23</span></p></td><td><p class=\"\"><span>Contract for Difference</span></p></td><td><p class=\"\"><span>Closing Short Position</span></p></td><td><p class=\"\"><span>25,981</span></p></td><td><p class=\"\"><span>5.8600 GBP</span></p></td></tr><tr><td><p class=\"\"><span>GB00BP9LHF23</span></p></td><td><p class=\"\"><span>Contract for Difference</span></p></td><td><p class=\"\"><span>Closing Short Position</span></p></td><td><p class=\"\"><span>3,346</span></p></td><td><p class=\"\"><span>5.8600 GBP</span></p></td></tr><tr><td><p class=\"\"><span>GB00BP9LHF23</span></p></td><td><p class=\"\"><span>Contract for Difference</span></p></td><td><p class=\"\"><span>Increasing Long Position</span></p></td><td><p class=\"\"><span>29,607</span></p></td><td><p class=\"\"><span>5.8600 GBP</span></p></td></tr><tr><td><p class=\"\"><span>GB00BP9LHF23</span></p></td><td><p class=\"\"><span>Contract for Difference</span></p></td><td><p class=\"\"><span>Increasing Short Position</span></p></td><td><p class=\"\"><span>-14,747</span></p></td><td><p class=\"\"><span>5.8600 GBP</span></p></td></tr><tr><td><p class=\"\"><span>GB00BP9LHF23</span></p></td><td><p class=\"\"><span>Contract for Difference</span></p></td><td><p class=\"\"><span>Increasing Short Position</span></p></td><td><p class=\"\"><span>-50,409</span></p></td><td><p class=\"\"><span>5.8600 GBP</span></p></td></tr><tr><td><p class=\"\"><span>GB00BP9LHF23</span></p></td><td><p class=\"\"><span>Contract for Difference</span></p></td><td><p class=\"\"><span>Increasing Short Position</span></p></td><td><p class=\"\"><span>-1,065</span></p></td><td><p class=\"\"><span>5.8600 GBP</span></p></td></tr><tr><td><p class=\"\"><span>GB00BP9LHF23</span></p></td><td><p class=\"\"><span>Contract for Difference</span></p></td><td><p class=\"\"><span>Increasing Short Position</span></p></td><td><p class=\"\"><span>-205,107</span></p></td><td><p class=\"\"><span>5.8600 GBP</span></p></td></tr><tr><td><p class=\"\"><span>GB00BP9LHF23</span></p></td><td><p class=\"\"><span>Contract for Difference</span></p></td><td><p class=\"\"><span>Increasing Short Position</span></p></td><td><p class=\"\"><span>-24,255</span></p></td><td><p class=\"\"><span>5.8600 GBP</span></p></td></tr><tr><td><p class=\"\"><span>GB00BP9LHF23</span></p></td><td><p class=\"\"><span>Contract for Difference</span></p></td><td><p class=\"\"><span>Reducing Short Position</span></p></td><td><p class=\"\"><span>45,514</span></p></td><td><p class=\"\"><span>5.8600 GBP</span></p></td></tr></tbody></table></div><p class=\"\"><span>(c)        Stock-settled derivative transactions (including options)</span></p><p class=\"\"><span>(i)         Writing, selling, purchasing or varying</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Class of relevant security</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Product description e.g. call option</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Writing, purchasing, selling, varying etc.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Number of securities to which option relates</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Exercise price per unit</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Type</span></p><p class=\"\"><span>e.g. American, European etc.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Expiry date</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Option money paid/ received per unit</span></p></li></ul><p class=\"\"><span>(ii)        Exercise</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Class of relevant security</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Product description</span></p><p class=\"\"><span>e.g. call option</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Exercising/ exercised against</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Number of securities</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Exercise price per unit</span></p></li></ul><p class=\"\"><span>(d)        Other dealings (including subscribing for new securities)</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Class of relevant security</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Nature of dealing</span></p><p class=\"\"><span>e.g. subscription, conversion</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Details</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Price per unit (if applicable)</span></p></li></ul><p class=\"\"><span>3.         OTHER INFORMATION</span></p><p class=\"\"><span>(a)        Indemnity and other dealing arrangements</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:</span></p><p class=\"\"><span>Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state \"none\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>None</span></p></li></ul><p class=\"\"><span>(b)        Agreements, arrangements or understandings relating to options or derivatives</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:</span></p><p class=\"\"><span>(i)  the voting rights of any relevant securities under any option; or</span></p><p class=\"\"><span>(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:</span></p><p class=\"\"><span>If there are no such agreements, arrangements or understandings, state \"none\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>None</span></p></li></ul><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><span>Date of disclosure:</span></td><td><p class=\"\"><span>26/02/2026</span></p></td></tr><tr><td><span>Contact name:</span></td><td><p class=\"\"><span>Compliance Control Room</span></p></td></tr><tr><td><span>Telephone number:</span></td><td><p class=\"\"><span>0207 595 9695</span></p></td></tr></tbody></table></div><p class=\"\"><span>Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. </span></p><p class=\"\"><span>The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.</span></p><p class=\"\"><span>The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.</span></p><span>This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.</span><p class=\"\"><span>RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END  FERBBGDDUGDDGLL</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026-02-26:newsml_RSZ5622Ua:0-reg-bnp-paribas-london-schroders-plc-form-8-5-ept-ri-schroders-bnp-paribas-group-sa/",
            "pub_date": "2026-02-26 19:05:36",
            "source": "London Stock Exchange",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_FWN3ZM11J:0",
            "title": "Cuckoo Homesys Q4 Operating Profit 66 Billion Won, Down 16% From Year Earlier",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Cuckoo Homesys Co Ltd </span><span>:</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>CUCKOO HOMESYS: Q4 OPERATING PROFIT 66 BILLION WON, DOWN 16% FROM YEAR EARLIER</span></p></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_FWN3ZM11J:0-cuckoo-homesys-q4-operating-profit-66-billion-won-down-16-from-year-earlier/",
            "pub_date": "2026-02-26 19:05:43",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_FWN3ZM0TX:0",
            "title": "Spotr Group Q4 EBITDA Loss SEK 1.4 Mln",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Spotr Group AB </span><span>:</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Q4 REVENUE AMOUNTED TO SEK 213 THOUSAND (SEK 1,627 THOUSAND)</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Q4 EBITDA AMOUNTED TO SEK -1,398 THOUSAND (SEK -2,458 THOUSAND)</span></p></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_FWN3ZM0TX:0-spotr-group-q4-ebitda-loss-sek-1-4-mln/",
            "pub_date": "2026-02-26 19:05:44",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "dpa_afx:4a80a774c6d3b:0",
            "title": "Eurozone Economic Sentiment Deteriorates",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div><span><p class=\"\"><span>BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Eurozone economic confidence weakened in February largely due to the significant drop in sentiment among services providers, survey data from the European Commission showed Thursday.</span></p><p class=\"\"><span>The economic sentiment index fell unexpectedly to 98.3 in February from 99.3 in the prior month. The score was forecast to rise to 99.8.</span></p><p class=\"\"><span>Services confidence weakened to a four-month low in February. The corresponding index slid to 5.0 from 6.8 in January. The reading was expected to climb to 7.5.</span></p><p class=\"\"><span>The industrial confidence indicator declined moderately to -7.1 from -6.8 in the prior month, while it was forecast to improve to -6.1.</span></p><p class=\"\"><span>Meanwhile, consumer sentiment improved to the highest since November 2024. The index stood at -12.2, unchanged from the flash estimate, and up from -12.4 in January.</span></p><p class=\"\"><span>Confidence among retailers also strengthened in February. The corresponding index climbed to -4.5 from -5.7. This was the highest since December 2024.</span></p><p class=\"\"><span>On the other hand, sentiment among contractors fell to a four-month low. The index dropped to -2.1 from -1.3.</span></p><p class=\"\"><span>Among the largest eurozone economies, the ESI dropped most significantly in France, followed by Italy. Meanwhile, confidence remained broadly stable in Spain and Germany.</span></p><p class=\"\"><span>The euro area employment expectations indicator declined to 97.6 from 98.2 in the previous month, the survey showed.</span></p><p class=\"\"><span>ING economist Bert Colijn said the economic confidence index was far more upbeat than other surveys in January, which makes the drop in February less of a concern.</span></p><p class=\"\"><span>The economist expects economic sentiment to remain upbeat, reflecting stronger expected activity over the year in line with a modest acceleration in economic growth.</span></p><p class=\"\"><span>Copyright(c) 2026 RTTNews.com. All Rights Reserved</span></p><p class=\"\"><span>Copyright RTT News/dpa-AFX</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/dpa_afx:4a80a774c6d3b:0-eurozone-economic-sentiment-deteriorates/",
            "pub_date": "2026-02-26 19:05:55",
            "source": "dpa-AFX",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L4N3ZM0YU:0",
            "title": "Royal Bank of Canada's first-quarter profit rises",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Royal Bank of Canada </span><span> posted a rise in first-quarter profit on Thursday, buoyed by strength in its capital markets and personal banking segments.</span></p><p class=\"\"><span>The lender posted adjusted net income of C$5.86 billion ($4.28 billion), or C$4.08 per share, compared with C$5.25 billion, or C$3.62 per share, a year earlier.</span></p><p class=\"\"><span>($1 = 1.3676 Canadian dollars)</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L4N3ZM0YU:0-royal-bank-of-canada-s-first-quarter-profit-rises/",
            "pub_date": "2026-02-26 19:05:58",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226004586_20260226004990:0",
            "title": "Privia Health 4Q Adj EPS 25c >PRVA",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226004586_20260226004990:0/",
            "pub_date": "2026-02-26 19:06:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226004484_20260226004988:0",
            "title": "Cascades Expects 1Q Performance to Decline Sequentially But Remain Above Year-Ago >CAS.T",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226004484_20260226004988:0/",
            "pub_date": "2026-02-26 19:06:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L4N3ZM0Z5:0",
            "title": "India markets regulator changes gold, silver valuation for mutual funds",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div><span><p class=\"\"><span>India's markets regulator on Thursday directed mutual funds to use domestic stock exchange spot prices to value their physical gold and silver holdings from April 1, 2026.</span></p><p class=\"\"><span>The Securities and Exchange Board of India (SEBI) said mutual funds may now use polled spot prices from recognized stock exchanges that settle physically delivered gold and silver derivatives contracts, ensuring that valuations reflect domestic market conditions.</span></p><p class=\"\"><span>The change moves away from the currently used London Bullion Market Association prices to arrive at the valuation of gold and silver held by exchange traded funds.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L4N3ZM0Z5:0-india-markets-regulator-changes-gold-silver-valuation-for-mutual-funds/",
            "pub_date": "2026-02-26 19:06:12",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:summary_document_report:quartr.com:2935514:0",
            "title": "CQP: Record 2025 net income of $2.99B on $10.76B revenue; expansion and credit upgrades highlight strong outlook",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>2025 saw record revenues of $10.76 billion and net income of $2.99 billion, driven by higher gas prices and derivative gains. Over 85% of production is contracted long-term, with a major expansion project targeting up to 20 mtpa pending FID. Credit ratings improved and distributions increased.</span></p><p class=\"\"><span>Original document: </span><a class=\"link-zw5jRdec\" href=\"https://www.tradingview.com/accounts/signin?next=https%3A%2F%2Fnews-mediator.tradingview.com%2Fdoc-screener%2Fv1%2Ffiles%2Furn%3Areport%3Aquartr.com%3A2935514-558edb6e2a7a53a39647dde9f6dea0bc\" target=\"_blank\">Cheniere Energy Partners, LP [CQP] SEC 10-K Annual Report — Feb. 26 2026</a></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_report:quartr.com:2935514:0-cqp-record-2025-net-income-of-2-99b-on-10-76b-revenue-expansion-and-credit-upgrades-highlight-strong-outlook/",
            "pub_date": "2026-02-26 19:06:21",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:summary_document_slides:quartr.com:2935530:0",
            "title": "IART: Q4 2025 saw revenue decline, margin compression, and a large net loss from goodwill impairment",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Q4 2025 revenue declined 1.7% year-over-year, with adjusted EPS down 14.4% and a significant net loss due to a goodwill impairment. Codman Specialty Surgical grew, while Tissue Technologies declined. 2026 guidance anticipates modest revenue growth and margin improvement.</span></p><p class=\"\"><span>Original document: </span><a class=\"link-zw5jRdec\" href=\"https://www.tradingview.com/accounts/signin?next=https%3A%2F%2Fnews-mediator.tradingview.com%2Fdoc-screener%2Fv1%2Ffiles%2Furn%3Aslides%3Aquartr.com%3A2935530-32c6b6f51374379e23010486d3a89399\" target=\"_blank\">Integra LifeSciences Holdings Corporation [IART] Slides Release — Feb. 26 2026</a></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_slides:quartr.com:2935530:0-iart-q4-2025-saw-revenue-decline-margin-compression-and-a-large-net-loss-from-goodwill-impairment/",
            "pub_date": "2026-02-26 19:06:32",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:summary_document_report:quartr.com:2935539:0",
            "title": "Granite Real Estate Investment Trust: NOI, FFO, and AFFO rose in Q4 2025, with high occupancy and strong 2026 growth outlook",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div><span><p class=\"\"><span>Q4 2025 saw strong NOI and net income growth, with FFO and AFFO per unit rising year-over-year. Occupancy reached 98%, rental spreads were robust, and guidance for 2026 anticipates further FFO and AFFO growth. Two new trustees were appointed.</span></p><p class=\"\"><span>Original document: </span><a class=\"link-zw5jRdec\" href=\"https://www.tradingview.com/accounts/signin?next=https%3A%2F%2Fnews-mediator.tradingview.com%2Fdoc-screener%2Fv1%2Ffiles%2Furn%3Areport%3Aquartr.com%3A2935539-069d44484d2b91fa63b1a52a832f0e02\" target=\"_blank\">Granite Real Estate Investment Trust Earnings Release — Feb. 26 2026</a></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_report:quartr.com:2935539:0-granite-real-estate-investment-trust-noi-ffo-and-affo-rose-in-q4-2025-with-high-occupancy-and-strong-2026-growth-outlook/",
            "pub_date": "2026-02-26 19:06:32",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226004493_20260226004496:0",
            "title": "Donaldson Co 2Q Sales $896.3M >DCI",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226004493_20260226004496:0/",
            "pub_date": "2026-02-26 19:00:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226004493_20260226004495:0",
            "title": "Donaldson Co 2Q Net $92.5M >DCI",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226004493_20260226004495:0/",
            "pub_date": "2026-02-26 19:00:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226004493_20260226004493:0",
            "title": "Donaldson Co 2Q EPS 78c >DCI",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226004493_20260226004493:0/",
            "pub_date": "2026-02-26 19:00:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226004493_20260226004494:0",
            "title": "Donaldson Co 2Q Adj EPS 83c >DCI",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226004493_20260226004494:0/",
            "pub_date": "2026-02-26 19:00:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L6N3ZL14V:0",
            "title": "Chinese influence operation targets Japan elections, Trump, other countries, US foundation says",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div><div class=\"summary-diQOvrPB\"><div class=\"summaryTitle-diQOvrPB\">Key points:</div><span><ul class=\"list-bmN0_SHH\"><li class=\"listItem-bmN0_SHH listItem--lightning-bmN0_SHH\"><span>Takaichi's office aware of foreign social media influence operation</span></li><li class=\"listItem-bmN0_SHH listItem--lightning-bmN0_SHH\"><span>Japan sees Chinese influence operations as a national security threat</span></li><li class=\"listItem-bmN0_SHH listItem--lightning-bmN0_SHH\"><span>Campaigns also target Trump, blame US and India for fentanyl crisis</span></li></ul></span></div><span><p class=\"\"><span>By AJ Vicens, Hina Suzuki and Kentaro Sugiyama</span></p><p class=\"\"><span>In the days surrounding Japanese Prime Minister Sanae Takaichi's February election win, several dozen X accounts linked to a Chinese misinformation campaign attacked her deeply conservative views and hawkish approach to China, said a U.S. research institute focused on national security and foreign policy. </span></p><p class=\"\"><span>The 35 accounts, along with nine channels on the microblogging site Tumblr, pushed corruption allegations and portrayed Takaichi as illegitimate and militaristic. The accounts suggest the prime minister is a reckless \"cult-backed\" leader driving Japan toward war, said Maria Riofrio, a researcher with the Foundation for Defense of Democracy's Center on Cyber and Technology Innovation. </span></p><p class=\"\"><span>The accounts, part of a network of at least 327 X and other social media accounts, have since December or earlier attacked adversaries of Beijing or pushed pro-China policy positions, and targeted human rights organizations and sought to influence domestic politics in Japan, the United States, the Philippines and Latin America, according to a new analysis by Riofrio.    </span></p><p class=\"\"><span>A spokesperson for Takaichi said her office is aware of suspicious foreign social media accounts that have posted content related to Japan's elections. </span></p><p class=\"\"><span>\"We consider this to be a national security threat that undermines the very foundations of democracy, including the fairness of elections and freedom of the press. We believe that countermeasures must be urgently prioritized.\" </span></p><p class=\"\"><span>Spokesperson Liu Pengyu for the Chinese Embassy in Washington said the \"analysis\" by the FDD was \"groundless.\"</span></p><p class=\"\"><span>\"The Chinese government consistently opposes and combats the use of fake accounts and other tactics to manipulate public opinion or spread disinformation,\" Liu said in a statement to Reuters. </span></p><p class=\"\"><span>\"We urge the relevant parties to stop making unfounded accusations and smearing others based on speculation.\"</span></p><p class=\"\"><span>Riofrio identified the most recent campaign as a distinct cluster based on its pro-China narratives that has coordinated on messaging content containing overlapping hashtags and other similarities. The cluster is likely part of long-running Chinese information operations that internet security analysts have dubbed Spamouflage or Dragonbridge, she said. </span></p><p class=\"\"><span>Although engagement with the material is low, users do see the content in social media feeds and the operators work algorithms to boost the content. One tweet that accused Takaichi of being in a cult, for example, received only two likes but was viewed more than 1,000 times. </span></p><p class=\"\"><span>The activity demonstrates \"China has the political will to interfere in Japanese elections and internal affairs,\" Riofrio said, noting that the overall cluster has similar operations targeting other countries, including the United States. </span></p><p class=\"\"><span>The FDD is a Washington-based nonprofit focused on \"strengthening U.S. national security and reducing or eliminating threats posed by adversaries and enemies of the United States and other free nations,\" according to its website. </span></p><p class=\"\"><span>ATTACKS ON TRUMP, ASIA-PACIFIC NATIONS</span></p><p class=\"\"><span>The Nikkei newspaper reported earlier this week on another set of suspected foreign-backed online operations attacking the Japanese elections. </span></p><p class=\"\"><span>Riofrio said nearly half of the 327 accounts attacked U.S. President </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://www.reuters.com/world/us/donald-trump/\" rel=\"nofollow\" target=\"_blank\">Donald Trump</a><span>, pushing the narrative that his drug and border policies have worsened America's fentanyl crisis, reversing gains made during the Biden era, while also deflecting blame from China, according to the FDD analysis. </span></p><p class=\"\"><span>In a coordinated sequence of messaging in early February on Trump and fentanyl, six accounts, despite having fewer than 10 followers each, attracted hundreds of likes, retweets and replies and nearly 18,000 views as of February 12, Riofrio said.</span></p><p class=\"\"><span>One account in the network, FentanylFreeA, created in December 2025, Riofrio said, seemingly seeks to emulate the U.S. Drug Enforcement Agency’s Fentanyl Free America campaign, using a similar name and identical imagery. The account attacks both the U.S. and India, which it blames as the source of fentanyl precursor drugs. </span></p><p class=\"\"><span>Neither the White House or the DEA responded to a request for comment. </span></p><p class=\"\"><span>The operations known as Spamouflage or Dragonbridge have been active since at least 2017 and have repeatedly targeted audiences around the world over the years, according to experts. </span></p><p class=\"\"><span>A spokesperson for Google’s Threat Intelligence Group said Dragonbridge is the most prolific pro-PRC information operations operator that it tracks as of early 2026 based on “its massive scale and assertive narrative agenda.” </span></p><p class=\"\"><span>Dragonbridge, while maintaining a foundational focus on targeting the U.S., overseas dissidents, government critics and international NGOs, has become notably more assertive in the Asia-Pacific, the Google spokesperson said, including by targeting the political leadership of Japan, Japan-Taiwan relations, Vietnam over its South China Sea activities, India and the Philippine administration. </span></p><p class=\"\"><span>OpenAI on Wednesday reported that it had disrupted attempts in mid-October by a Chinese law enforcement official to help plan a multi-stage information attack on Takaichi. </span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L6N3ZL14V:0-chinese-influence-operation-targets-japan-elections-trump-other-countries-us-foundation-says/",
            "pub_date": "2026-02-26 19:00:00",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226004522_20260226004522:0",
            "title": "Cemex To Acquire Omega Products International, A Leading Stucco Manufacturer In The Western U.S. >CX",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226004522_20260226004522:0/",
            "pub_date": "2026-02-26 19:00:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226004484_20260226004486:0",
            "title": "Cascades 4Q Sales C$1.2B >CAS.T",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226004484_20260226004486:0/",
            "pub_date": "2026-02-26 19:00:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226004484_20260226004485:0",
            "title": "Cascades 4Q Net C$37M >CAS.T",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226004484_20260226004485:0/",
            "pub_date": "2026-02-26 19:00:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226004484_20260226004484:0",
            "title": "Cascades 4Q EPS C$0.36 >CAS.T",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226004484_20260226004484:0/",
            "pub_date": "2026-02-26 19:00:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226004460:0",
            "title": "Calendar of U.S. Earnings Expected in the Week Ahead",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div><span><p class=\"\"><span>Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.</span></p><pre class=\"preformatted-zagxxLT_\" data-no-swipe=\"true\"><span>Company                                   Symbol     Quarter  Mean  Report Time </span><br/><span> </span><br/><span>· </span><br/><span>·Thursday </span><br/><span>·ACI Worldwide                             (ACIW)        4Q       .80 </span><br/><span>·ACM Research A                            (ACMR)        4Q       .44       BMO </span><br/><span>·Acushnet Hldgs                            (GOLF)        4Q      (.30)  6:30 AM </span><br/><span>·AES Corp.                                 (AES)         4Q       .62 </span><br/><span>·Aeva Tech Inc                             (AEVA)        4Q      (.44)      AMC </span><br/><span>·Airgain Inc.                              (AIRG)        4Q      (.02)  4:05 PM </span><br/><span>·Akebia Therap.                            (AKBA)        4Q      (.04)  7:00 AM </span><br/><span>·Alignment Health                          (ALHC)        4Q      (.15)  4:01 PM </span><br/><span>·Alpha Teknova                             (TKNO)        4Q      (.09)  4:01 PM </span><br/><span>·Alta Equip Grp                            (ALTG)        4Q      (.30)      AMC </span><br/><span>·Ambarella Inc.                            (AMBA)        4Q       .10   4:05 PM </span><br/><span>·Amer Health REIT                          (AHR)         4Q       .15       AMC </span><br/><span>·Amphastar Pharm                           (AMPH)        4Q       .92   4:05 PM </span><br/><span>·Applied Opto                              (AAOI)        4Q      (.11)  4:10 PM </span><br/><span>·Arbe Robotics                             (ARBE)        4Q      (.09)  7:00 AM </span><br/><span>·Arcellx Inc.                              (ACLX)        4Q     (1.04) </span><br/><span>·Arcosa Inc.                               (ACA)         4Q       .92       AMC </span><br/><span>·Ardagh Metal                              (AMBP)        4Q       .02   7:00 AM </span><br/><span>·argenx ADR                                (ARGX)        4Q      5.95   1:00 AM </span><br/><span>·Arhaus Inc. A                             (ARHS)        4Q       .09       BMO </span><br/><span>·Arlo Tech Inc                             (ARLO)        4Q       .16       AMC </span><br/><span>·Assured Guaranty                          (AGO)         4Q      1.45   4:00 PM </span><br/><span>·Asure Software                            (ASUR)        4Q       .26   4:01 PM </span><br/><span>·Aura Minerals                             (AUGO)        4Q      1.48       AMC </span><br/><span>·Aurinia Pharm                             (AUPH)        4Q       .22   6:00 AM </span><br/><span>·Autodesk Inc.                             (ADSK)        4Q      2.64   4:01 PM </span><br/><span>·AvePoint Inc. A                           (AVPT)        4Q       .09   4:05 PM </span><br/><span>·AXIA Energia ADR                          (AXIA)        4Q       .18       AMC </span><br/><span>·AXIA Pfd B                                (AXIA.P)      4Q       .18       AMC </span><br/><span>·Baidu ADR                                 (BIDU)        4Q      1.41   4:00 AM </span><br/><span>·Bain Cap Finance                          (BCSF)        4Q       .47       AMC </span><br/><span>·Baldwin Insur.                            (BWIN)        4Q       .29   4:05 PM </span><br/><span>·Bentley Sys B                             (BSY)         4Q       .26   7:00 AM </span><br/><span>·BeOne Med ADR                             (ONC)         4Q      1.29       BMO </span><br/><span>·BioCryst Pharm                            (BCRX)        4Q       .05   7:00 AM </span><br/><span>·Biodesix Inc.                             (BDSX)        4Q      (.86)      AMC </span><br/><span>·BioLife Solut.                            (BLFS)        4Q      (.01)  4:03 PM </span><br/><span>·BlackSky Tech A                           (BKSY)        4Q      (.26)  7:00 AM </span><br/><span>·Block Inc. A                              (XYZ)         4Q       .64   4:05 PM </span><br/><span>·Brink's Company                           (BCO)         4Q      2.47   4:00 PM </span><br/><span>·Burford Capital                           (BUR)         4Q       .37   8:00 AM </span><br/><span>·Butterfly Net A                           (BFLY)        4Q      (.04)  6:30 AM </span><br/><span>·Cable One Inc.                            (CABO)        4Q      6.60   4:15 PM </span><br/><span>·CIBC                                      (CM)          1Q      1.76   5:30 AM </span><br/><span>·Caris Life Sci                            (CAI)         4Q       .03       AMC </span><br/><span>·Cars.com Inc.                             (CARS)        4Q       .54   7:30 AM </span><br/><span>·Castle Bio                                (CSTL)        4Q      (.26)      AMC </span><br/><span>·Celsius Hldgs                             (CELH)        4Q       .18       BMO </span><br/><span>·Certara Inc.                              (CERT)        4Q       .11   4:15 PM </span><br/><span>·Cheniere Energy                           (LNG)         4Q      3.80   7:30 AM </span><br/><span>·Clear Channel                             (CCO)         4Q       .01   7:00 AM </span><br/><span>·Clover Health A                           (CLOV)        4Q      (.10)  4:05 PM </span><br/><span>·Cmb.Tech Nv                               (CMBT)        4Q       .37   2:00 AM </span><br/><span>·Codexis Inc.                              (CDXS)        4Q      (.03) </span><br/><span>·Collegium Phrm                            (COLL)        4Q      2.14       BMO </span><br/><span>·Compass                                   (COMP.EQ)     4Q      (.06)      AMC </span><br/><span>·COMPASS ADR                               (CMPS)        4Q      (.40) </span><br/><span>·Concentra Grp                             (CON)         1Q       .35       AMC </span><br/><span>·CoreWeave Inc A                           (CRWV)        4Q      (.50)      AMC </span><br/><span>·Coterra Energy                            (CTRA)        4Q       .47       AMC </span><br/><span>·Coupang Inc. A                            (CPNG)        4Q       .03       AMC </span><br/><span>·CRA Intl Inc                              (CRAI)        4Q      2.07   8:05 AM </span><br/><span>·Crinetics Pharm                           (CRNX)        4Q     (1.35)  4:05 PM </span><br/><span>·Cronos Grp                                (CRON)        4Q       .02       BMO </span><br/><span>·CubeSmart                                 (CUBE)        4Q       .37       AMC </span><br/><span>·Cytek Bio                                 (CTKB)        4Q      (.02)  4:05 PM </span><br/><span>·D-Wave Quantum                            (QBTS)        4Q      (.06)      BMO </span><br/><span>·Daqo New ADR                              (DQ)          4Q      (.20)      BMO </span><br/><span>·Data I/O Corp                             (DAIO)        4Q      (.11)      AMC </span><br/><span>·Definitive HC A                           (DH)          4Q       .06   4:05 PM </span><br/><span>·Definium Therap                           (DFTX)        4Q      (.48)      AMC </span><br/><span>·Delcath Syss                              (DCTH)        4Q      (.06)      BMO </span><br/><span>·Dell Tech Cl C                            (DELL)        4Q      3.53   4:05 PM </span><br/><span>·DENTSPLY SIRONA                           (XRAY)        4Q       .28       AMC </span><br/><span>·DiamondRock                               (DRH)         4Q       .08       AMC </span><br/><span>·Donaldson Co                              (DCI)         2Q       .89   6:00 AM </span><br/><span>·DoubleVerify                              (DV)          4Q       .16       AMC </span><br/><span>·Ducommun Inc                              (DCO)         4Q       .97   6:00 AM </span><br/><span>·Duolingo Inc A                            (DUOL)        4Q       .84   4:01 PM </span><br/><span>·Dyne Therap.                              (DYN)         4Q      (.76) </span><br/><span>·Ecovyst Inc                               (ECVT)        4Q       .15   6:00 AM </span><br/><span>·Elastic NV                                (ESTC)        3Q       .65   4:05 PM </span><br/><span>·EMCOR Grp Inc                             (EME)         4Q      6.68   7:30 AM </span><br/><span>·Enerflex Ltd.                             (EFXT)        4Q       .13       BMO </span><br/><span>·Eni S.p.A. ADR                            (E)           4Q       .74 </span><br/><span>·Enovis Corp                               (ENOV)        4Q       .84       BMO </span><br/><span>·Eos Energy A                              (EOSE)        4Q      (.17)      BMO </span><br/><span>·EVERTEC Inc.                              (EVTC)        4Q       .90       AMC </span><br/><span>·Expensify Inc A                           (EXFY)        4Q       .04   4:00 PM </span><br/><span>·Fidus Invest                              (FDUS)        4Q       .50       AMC </span><br/><span>·FIGS Inc.                                 (FIGS)        4Q       .02   4:05 PM </span><br/><span>·Figure Tech A                             (FIGR)        4Q       .15       AMC </span><br/><span>·First Advantage                           (FA)          4Q       .26       BMO </span><br/><span>·Flowco Hldgs A                            (FLOC)        4Q       .32   6:00 AM </span><br/><span>·Flutter Ent.                              (FLUT)        4Q      1.89   4:05 PM </span><br/><span>·Fortrea Hldgs                             (FTRE)        4Q       .17       BMO </span><br/><span>·Fox Factory                               (FOXF)        4Q       .16   4:05 PM </span><br/><span>·Frontdoor Inc.                            (FTDR)        4Q       .13       BMO </span><br/><span>·FTAI Infra                                (FIP)         4Q      (.43)      AMC </span><br/><span>·FTI Consulting                            (FCN)         4Q      1.46   7:30 AM </span><br/><span>·GH Research Plc                           (GHRS)        4Q      (.27) </span><br/><span>·Gildan Active                             (GIL)         4Q       .96       BMO </span><br/><span>·Globant SA                                (GLOB)        4Q      1.54       AMC </span><br/><span>·Golden Ent.                               (GDEN)        4Q       .16 </span><br/><span>·Goldman Sachs                             (GSBD)        4Q       .35       AMC </span><br/><span>·Gray Media Inc.                           (GTN)         4Q      (.28)      BMO </span><br/><span>·Gray Media A                              (GTN.A)       4Q      (.28)      BMO </span><br/><span>·Great Elm Cap                             (GECC)        4Q       .35 </span><br/><span>·Grindr Inc.                               (GRND)        4Q       .12   4:05 PM </span><br/><span>·H2O America                               (HTO)         4Q       .48       AMC </span><br/><span>·Hafnia Limited                            (HAFN)        4Q       .21   1:30 AM </span><br/><span>·Hagerty Inc A                             (HGTY)        4Q       .03       BMO </span><br/><span>·Heron Therap.                             (HRTX)        4Q      (.02)      BMO </span><br/><span>·Hertz Hldgs                               (HTZ)         4Q      (.52)  8:00 AM </span><br/><span>·Hilton Grand                              (HGV)         4Q      1.12       AMC </span><br/><span>·Hormel Foods                              (HRL)         1Q       .32   6:30 AM </span><br/><span>·Hudson Pacific                            (HPP)         4Q      (.55)      BMO </span><br/><span>·ICF Intl. Inc.                            (ICFI)        4Q      1.49   4:05 PM </span><br/><span>·INmune Bio Inc.                           (INMB)        4Q      (.26) </span><br/><span>·Innodata Inc.                             (INOD)        4Q       .21       AMC </span><br/><span>·Installed Bldg.                           (IBP)         4Q      2.75   7:30 AM </span><br/><span>·Integra LifeSci                           (IART)        4Q       .80       BMO </span><br/><span>·Intellia Therap.                          (NTLA)        4Q      (.95)      BMO </span><br/><span>·Intl. Seaways                             (INSW)        4Q      2.09   6:45 AM </span><br/><span>·Intuit Inc.                               (INTU)        2Q      3.68   4:00 PM </span><br/><span>·iQIYI Inc. ADR                            (IQ)          4Q       .01   4:00 AM </span><br/><span>·J.M. Smucker Co.                          (SJM)         3Q      2.27   7:00 AM </span><br/><span>·KBR Inc.                                  (KBR)         4Q       .95   6:00 AM </span><br/><span>·Kimbell Royalty                           (KRP)         4Q       .14   7:00 AM </span><br/><span>·Koppers Hldgs.                            (KOP)         4Q       .59   7:55 AM </span><br/><span>·Korea Elec. ADR                           (KEP)         4Q       .78 </span><br/><span>·Krispy Kreme                              (DNUT)        4Q       .03   6:45 AM </span><br/><span>·Kymera Therap.                            (KYMR)        4Q      (.80)  7:00 AM </span><br/><span>·Lantheus Hldgs.                           (LNTH)        4Q      1.19   7:00 AM </span><br/><span>·Liberty Formula A                         (FWONA)       4Q       .37   8:15 AM </span><br/><span>·Liberty Formula C                         (FWONK)       4Q       .37   8:15 AM </span><br/><span>·Ligand Pharm.                             (LGND)        4Q      1.50   7:00 AM </span><br/><span>·Lindblad Exped.                           (LIND)        4Q      (.32)  7:30 AM </span><br/><span>·Loar Hldgs. Inc.                          (LOAR)        4Q       .19   8:30 AM </span><br/><span>·Main Street Cap.                          (MAIN)        4Q      1.03       AMC </span><br/><span>·MannKind Corp.                            (MNKD)        4Q       .02       BMO </span><br/><span>·MARA Hldgs. Inc.                          (MARA)        4Q     (1.18)      AMC </span><br/><span>·Marcus Corp.                              (MCS)         4Q       .06   7:45 AM </span><br/><span>·Masimo Corp.                              (MASI)        4Q      1.48   4:05 PM </span><br/><span>·MasTec Inc.                               (MTZ)         4Q      1.95       AMC </span><br/><span>·MBIA Inc.                                 (MBI)         4Q      (.10)  4:15 PM </span><br/><span>·MDxHealth S.A.                            (MDXH)        4Q      (.13)  4:00 PM </span><br/><span>·MidCap Fin. Inv.                          (MFIC)        4Q       .37       AMC </span><br/><span>·Middleby Corp.                            (MIDD)        4Q      2.27   7:00 AM </span><br/><span>·Millicom Intl.                            (TIGO)        4Q       .80   6:00 AM </span><br/><span>·Millrose Prop.                            (MRP)         4Q       .74       BMO </span><br/><span>·Monster Beverage                          (MNST)        4Q       .48   4:10 PM </span><br/><span>·Morgan Stanley                            (MSDL)        4Q       .49       AMC </span><br/><span>·MP Materials                              (MP)          4Q       .00   4:05 PM </span><br/><span>·MSC Income Fund                           (MSIF)        4Q       .36 </span><br/><span>·Natera Inc.                               (NTRA)        4Q      (.51)  4:05 PM </span><br/><span>·Natl CineMedia                            (NCMI)        4Q       .20   4:05 PM </span><br/><span>·Natl. Health Inv.                         (NHI)         4Q       .79       AMC </span><br/><span>·NCR Atleos Corp.                          (NATL)        4Q      1.36       AMC </span><br/><span>·NCR Voyix Corp.                           (VYX)         4Q       .29       BMO </span><br/><span>·Nerdy Inc.                                (NRDY)        4Q      (.03)  4:01 PM </span><br/><span>·NetApp Inc.                               (NTAP)        3Q      2.06   4:01 PM </span><br/><span>·Nexa Resources                            (NEXA)        4Q       .58       AMC </span><br/><span>·NexPoint Real Est                         (NREF)        4Q       .49       BMO </span><br/><span>·Nexstar Media                             (NXST)        4Q      3.72   7:00 AM </span><br/><span>·NextCure Inc.                             (NXTC)        4Q     (2.29) </span><br/><span>·nLIGHT Inc.                               (LASR)        4Q       .11   4:10 PM </span><br/><span>·Nomad Foods Ltd.                          (NOMD)        4Q       .51   6:45 AM </span><br/><span>·Novavax Inc.                              (NVAX)        4Q      (.48)      BMO </span><br/><span>·NovoCure Ltd.                             (NVCR)        4Q      (.41) </span><br/><span>·NuScale Power                             (SMR)         4Q      (.15)  4:15 PM </span><br/><span>·Nuveen Churchill                          (NCDL)        4Q       .43   7:15 AM </span><br/><span>·OneSpan Inc.                              (OSPN)        4Q       .29   4:01 PM </span><br/><span>·Onestream Inc.                            (OS)          4Q       .05   4:05 PM </span><br/><span>·Opera Ltd. ADR                            (OPRA)        4Q       .24       BMO </span><br/><span>·OPKO Health Inc.                          (OPK)         4Q      (.07)  4:05 PM </span><br/><span>·Oportun Fincl                             (OPRT)        4Q       .26   4:05 PM </span><br/><span>·OrthoPediatrics                           (KIDS)        4Q      (.29)      AMC </span><br/><span>·Pacira BioSci.                            (PCRX)        4Q       .90   4:00 PM </span><br/><span>·Palmer Square BDC                         (FSBD)        4Q       .42   7:00 AM </span><br/><span>·Papa John's                               (PZZA)        4Q       .33   7:00 AM </span><br/><span>·PAR Tech                                  (PAR)         4Q       .06   3:00 PM </span><br/><span>·Payoneer Global                           (PAYO)        4Q       .06   7:30 AM </span><br/><span>·Pembina Pipeline                          (PBA)         4Q       .53       AMC </span><br/><span>·PENN Ent.                                 (PENN)        4Q      (.15)  7:00 AM </span><br/><span>·Perrigo Co. plc                           (PRGO)        4Q       .78       BMO </span><br/><span>·Personalis Inc.                           (PSNL)        4Q      (.29)  4:01 PM </span><br/><span>·Phathom Pharm.                            (PHAT)        4Q      (.41)      BMO </span><br/><span>·Playtika Hldg                             (PLTK)        4Q       .14   6:35 AM </span><br/><span>·Primo Brands Corp                         (PRMB)        4Q       .20   6:00 AM </span><br/><span>·Privia Health                             (PRVA)        4Q       .03   7:00 AM </span><br/><span>·Progyny Inc.                              (PGNY)        4Q       .15       AMC </span><br/><span>·PSEG Inc                                  (PEG)         4Q       .71   7:30 AM </span><br/><span>·PubMatic Inc.                             (PUBM)        4Q      (.01)  4:05 PM </span><br/><span>·PureCycle Tech.                           (PCT)         4Q      (.25)  4:05 PM </span><br/><span>·Qnity Electronics                         (Q)           4Q       .63       BMO </span><br/><span>·Rackspace Tech.                           (RXT)         4Q      (.04)  8:00 AM </span><br/><span>·RealReal Inc.                             (REAL)        4Q       .04       AMC </span><br/><span>·Relay Therap.                             (RLAY)        4Q      (.40)      AMC </span><br/><span>·Rhythm Pharm.                             (RYTM)        4Q      (.80)  7:00 AM </span><br/><span>·RLJ Lodging Trust                         (RLJ)         4Q      (.07)      AMC </span><br/><span>·Rocket Companies                          (RKT)         4Q       .09   4:05 PM </span><br/><span>·Rocket Lab Corp                           (RKLB)        4Q      (.10)      AMC </span><br/><span>·Royal Bank Can.                           (RY)          1Q      2.82   6:00 AM </span><br/><span>·SBA Comm. Corp.                           (SBAC)        4Q      3.79   4:01 PM </span><br/><span>·Sempra                                    (SRE)         4Q      1.24   8:00 AM </span><br/><span>·Shake Shack Inc.                          (SHAK)        4Q       .34   7:00 AM </span><br/><span>·Shift4 Payments                           (FOUR)        4Q      1.60 </span><br/><span>·SQM ADR                                   (SQM)         4Q       .80 </span><br/><span>·Solventum Corp.                           (SOLV)        4Q      1.49   4:05 PM </span><br/><span>·SoundHound AI                             (SOUN)        4Q      (.10)      AMC </span><br/><span>·Sprout Social                             (SPT)         4Q       .16   4:05 PM </span><br/><span>·Standard Motor                            (SMP)         4Q       .49   8:30 AM </span><br/><span>·Starz Ent. Corp                           (STRZ)        4Q      (.57)  4:05 PM </span><br/><span>·Stellantis N.V.                           (STLA)        4Q       .57 </span><br/><span>·Strategic Edu.                            (STRA)        4Q      1.41       AMC </span><br/><span>·Sunrun Inc.                               (RUN)         4Q       .03       AMC </span><br/><span>·Sweetgreen Inc.                           (SG)          4Q      (.31)  4:05 PM </span><br/><span>·Syndax Pharm.                             (SNDX)        4Q      (.58)      AMC </span><br/><span>·T1 Energy Inc.                            (TE)          4Q      (.01) </span><br/><span>·Talen Energy Corp                         (TLN)         4Q      2.62       AMC </span><br/><span>·Tecnoglass Inc.                           (TGLS)        4Q       .84   7:00 AM </span><br/><span>·Teleflex Inc.                             (TFX)         4Q      3.76   6:30 AM </span><br/><span>·TeraWulf Inc.                             (WULF)        4Q      (.13)      AMC </span><br/><span>·TG Therap.                                (TGTX)        4Q       .35       BMO </span><br/><span>·Thryv Hldgs.                              (THRY)        4Q       .18   7:30 AM </span><br/><span>·Tidewater Inc.                            (TDW)         4Q       .77 </span><br/><span>·Titan Intl. Inc.                          (TWI)         4Q      (.28)      BMO </span><br/><span>·TopBuild Corp.                            (BLD)         4Q      4.54   7:00 AM </span><br/><span>·Toronto-Dom. Bank                         (TD)          1Q      1.66   6:30 AM </span><br/><span>·Treace Med.                               (TMCI)        4Q      (.15)  4:05 PM </span><br/><span>·TTEC Hldgs. Inc.                          (TTEC)        4Q       .36       AMC </span><br/><span>·Tutor Perini Corp                         (TPC)         4Q       .58   4:15 PM </span><br/><span>·United Parks                              (PRKS)        4Q       .55   6:30 AM </span><br/><span>·USA TODAY Co.                             (TDAY)        4Q      (.36)  8:00 AM </span></pre></span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226004460:0/",
            "pub_date": "2026-02-26 19:00:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226004525:0",
            "title": "Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Full Year 2025 LUPKYNIS Sales Grew 25%</span></p><p class=\"\"><span>Announces LUPKYNIS Sales Guidance for 2026 of $305 Million to $315 Million</span></p><p class=\"\"><span>ROCKVILLE, Md. &amp; EDMONTON, Alberta--(BUSINESS WIRE)--February 26, 2026--</span></p><p class=\"\"><span>Aurinia Pharmaceuticals Inc. </span><span> today announced financial results for the three and twelve months ended December 31, 2025 and provided an update on recent business progress.</span></p><p class=\"\"><span>Financial Results</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Total Revenue: For the three and twelve months ended December 31, 2025,   total revenue was $77.1 million and $283.1 million, up 29% and 20%,   respectively, compared to $59.9 million and $235.1 million, respectively,   for the same periods of 2024.   </span><br/><span> -- Net Product Sales: For the three and twelve months ended </span><br/><span> December 31, 2025, net product sales of LUPKYNIS, the first   FDA-approved oral therapy for the treatment of adult patients with   active lupus nephritis, were $74.2 million and $271.3 million, up   29% and 25%, respectively, compared to $57.6 million and $216.2   million, respectively, for the same periods of 2024.   </span><br/><span> -- License, Collaboration and Royalty Revenue: For the three and </span><br/><span> twelve months ended December 31, 2025, license, collaboration and   royalty revenue, which includes manufacturing services,   collaboration and royalty revenue from Aurinia's collaboration   partner, Otsuka, was $2.9 million and $11.7 million, up 26% and   down 38%, respectively, compared to $2.3 million and $18.9 million,   respectively, for the same periods of 2024. The twelve months   ended December 31, 2024 included a milestone payment of $10.0   million associated with LUPKYNIS regulatory approval in Japan.       </span></li><li class=\"listItem-bmN0_SHH\"><span>Net Income: For the three and twelve months ended December 31, 2025,   net income was $210.8 million and $287.2 million, up 14957% and 4852%,   respectively, compared to $1.4 million and $5.8 million, respectively,   for the same periods of 2024. For the three and twelve months ended   December 31, 2025, the Company recorded an income tax benefit of $175.1   million and $173.0 million, respectively, primarily due to the release of   its valuation allowance on deferred tax assets that the Company now   expects to realize. For the three and twelve months ended December 31,   2025, net income before income taxes was $35.7 million and $114.2 million,   up 2875% and 1443%, respectively, compared to $1.2 million and $7.4   million, respectively, for the same periods of 2024.   </span></li><li class=\"listItem-bmN0_SHH\"><span>Diluted Earnings per Share: For the three and twelve months ended   December 31, 2025, diluted earnings per share was $1.53 and $2.07, up   15200% and 5075%, respectively, compared to $0.01 and $0.04, respectively,   for the same periods of 2024.   </span></li><li class=\"listItem-bmN0_SHH\"><span>Cash Flows from Operating Activities: For the three and twelve months   ended December 31, 2025, cash flows from operating activities were $45.7   million and $135.7 million, up 52% and 206%, respectively, compared to   $30.1 million and $44.4 million, respectively, for the same periods of   2024. </span></li></ul><p class=\"\"><span>Cash Position</span></p><p class=\"\"><span>As of December 31, 2025, Aurinia had cash, cash equivalents, restricted cash and investments of $398.0 million, compared to $358.5 million at December 31, 2024. For the year ended December 31, 2025, the Company repurchased 12.2 million of its common shares for $98.2 million.</span></p><p class=\"\"><span>2026 Total Revenue and Net Product Sales Guidance</span></p><p class=\"\"><span>For 2026, Aurinia expects total revenue of $315 million to $325 million, up 11% to 15% compared to 2025, and net product sales of $305 million to $315 million, up 12% to 16% compared to 2025.</span></p><p class=\"\"><span>\"We are pleased to have delivered strong LUPKYNIS sales growth in 2025,\" stated Peter Greenleaf, President and Chief Executive Officer of Aurinia. \"We expect 2026 to be an exciting year for Aurinia. We remain focused on increasing LUPKYNIS adoption among lupus nephritis patients and advancing aritinercept, a dual BAFF/APRIL inhibitor, which has the potential to treat a wide range of autoimmune diseases. We have initiated a clinical study of aritinercept in one autoimmune disease and plan to initiate a clinical study in an additional autoimmune disease in the first half of 2026.\"</span></p><p class=\"\"><span>Webcast &amp; Conference Call Details</span></p><p class=\"\"><span>A webcast and conference call will be hosted today, February 26th, at 8:30 a.m. ET. The link to the audio webcast is available here. To join the conference call, please dial 877-407-8029/+1 201-689-8029. A replay of the webcast will be available on Aurinia's website.</span></p><p class=\"\"><span>About Aurinia</span></p><p class=\"\"><span>Aurinia is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. In January 2021, the Company introduced LUPKYNIS(R) (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. Aurinia is also developing aritinercept, a dual inhibitor of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) for the potential treatment of autoimmune diseases.</span></p><p class=\"\"><span>Forward-Looking Statements</span></p><p class=\"\"><span>This press release contains forward-looking information within the meaning of applicable Canadian securities law and forward-looking statements within the meaning of applicable U.S. securities law. We caution investors that forward-looking statements are based on management's expectations and assumptions as of the date of this press release and involve substantial risks and uncertainties that could cause the actual outcomes to differ materially from what we currently expect. These risks and uncertainties include, but are not limited to, those associated with: LUPKYNIS net product sales, the timing of clinical study results and other risks and uncertainties identified in our filings with the U.S. Securities and Exchange Commission. Forward-looking statements in this press release apply only as of the date made, and we undertake no obligation to update or revise any forward-looking statements to reflect subsequent events or circumstances. Additional information related to Aurinia, including a detailed list of the risks and uncertainties affecting Aurinia and its business, can be found in Aurinia's most recent Annual Report on Form 10-K and its other public filings available by accessing the Canadian Securities Administrators' System for Electronic Document Analysis and Retrieval (SEDAR) website at www.sedarplus.ca or the U.S. Securities and Exchange Commission's Electronic Document Gathering and Retrieval System (EDGAR) website at www.sec.gov/edgar, and on Aurinia's website at www.auriniapharma.com.</span></p><pre class=\"preformatted-zagxxLT_\" data-no-swipe=\"true\"><span> </span><br/><span>              AURINIA PHARMACEUTICALS INC. AND SUBSIDIARY </span><br/><span>                      CONSOLIDATED BALANCE SHEETS </span><br/><span>                             (in thousands) </span><br/><span> </span><br/><span>                               December 31, 2025     December 31, 2024 </span><br/><span>                              -------------------  --------------------- </span><br/><span>ASSETS </span><br/><span>Current assets: </span><br/><span>     Cash, cash equivalents </span><br/><span>      and restricted cash      $          80,213    $          83,433 </span><br/><span>     Short-term investments              317,784              275,043 </span><br/><span>     Accounts receivable, </span><br/><span>      net                                 41,454               36,544 </span><br/><span>     Inventory                            45,690               39,228 </span><br/><span>     Prepaid expenses and </span><br/><span>      deposits                             5,746               11,219 </span><br/><span>     Other current assets                  1,080                1,129 </span><br/><span>                                  --------------       -------------- </span><br/><span>Total current assets                     491,967              446,596 </span><br/><span>                                  --------------       -------------- </span><br/><span>Deferred tax assets, net                 176,194                   -- </span><br/><span>Finance right-of-use lease </span><br/><span> assets                                   73,865               92,072 </span><br/><span>Intangible assets, net                     3,761                4,355 </span><br/><span>Operating right-of-use lease </span><br/><span> assets                                    3,596                4,068 </span><br/><span>Property and equipment, net                2,111                2,731 </span><br/><span>Other noncurrent assets                       93                  823 </span><br/><span>                                  --------------       -------------- </span><br/><span>Total assets                   $         751,587    $         550,645 </span><br/><span>                                  ==============       ============== </span><br/><span> </span><br/><span>LIABILITIES AND </span><br/><span>SHAREHOLDERS' EQUITY </span><br/><span>Current liabilities: </span><br/><span>     Accounts payable          $           3,313    $           5,187 </span><br/><span>     Accrued expenses                     66,621               64,971 </span><br/><span>     Finance lease </span><br/><span>      liabilities, current </span><br/><span>      portion                             16,523               14,046 </span><br/><span>     Deferred revenue                      3,720               11,002 </span><br/><span>     Operating lease </span><br/><span>      liabilities, current </span><br/><span>      portion                              1,067                1,026 </span><br/><span>     Other current </span><br/><span>      liabilities                          2,480                1,531 </span><br/><span>                                  --------------       -------------- </span><br/><span>Total current liabilities                 93,724               97,763 </span><br/><span>                                  --------------       -------------- </span><br/><span>Finance lease liabilities, </span><br/><span> less current portion                     52,322               58,554 </span><br/><span>Deferred revenue, less </span><br/><span> current portion                          12,648                1,699 </span><br/><span>Deferred compensation and </span><br/><span> other noncurrent </span><br/><span> liabilities                               6,662                9,408 </span><br/><span>Operating lease liabilities, </span><br/><span> less current portion                      4,900                5,743 </span><br/><span>                                  --------------       -------------- </span><br/><span>Total liabilities                        170,256              173,167 </span><br/><span>                                  --------------       -------------- </span><br/><span>Shareholders' equity </span><br/><span>Common shares - no par </span><br/><span> value, Unlimited shares </span><br/><span> authorized, 132,323 and </span><br/><span> 140,883 shares issued and </span><br/><span> outstanding at December 31, </span></pre></span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226004525:0/",
            "pub_date": "2026-02-26 19:00:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226004502_20260226004503:0",
            "title": "ACI Worldwide 4Q Net $64.3M >ACIW",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226004502_20260226004503:0/",
            "pub_date": "2026-02-26 19:00:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226004502_20260226004502:0",
            "title": "ACI Worldwide 4Q EPS 62c >ACIW",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226004502_20260226004502:0/",
            "pub_date": "2026-02-26 19:00:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226004393_20260226004394:0",
            "title": "7-Eleven Malaysia 4Q Loss/Shr MYR0.0007",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226004393_20260226004394:0/",
            "pub_date": "2026-02-26 18:52:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226004393_20260226004393:0",
            "title": "7-Eleven Malaysia 4Q Loss MYR726,000",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226004393_20260226004393:0/",
            "pub_date": "2026-02-26 18:52:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026-02-26:newsml_EduC2PMSa:0",
            "title": "REG - Euronext Dublin - 2025 (KINGSPAN GROUP PLC) [89173]",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>This announcement has been issued through the Companies Announcement ServiceofEuronext Dublin.</span></p><p class=\"\"><span>To view the announcement in full, please click on the associated attachment</span></p><p class=\"\"><span>https://newsserviceweb.oslobors.no/message/89173</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026-02-26:newsml_EduC2PMSa:0-reg-euronext-dublin-2025-kingspan-group-plc-89173/",
            "pub_date": "2026-02-26 18:52:38",
            "source": "Oslo Stock Exchange",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026-02-26:newsml_RSZ5601Ua:0",
            "title": "REG - BNP Paribas London Beazley PLC - Form 8.5 (EPT/RI) Beazley Plc BNPP Financial MKTS",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><span>RNS Number : 5601U  BNP Paribas London  26 February 2026   </span><p class=\"\"><span>FORM 8.5 (EPT/RI)</span></p><p class=\"\"><span>PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY</span></p><p class=\"\"><span>Rule 8.5 of the Takeover Code (the \"Code\")</span></p><p class=\"\"><span>1.         KEY INFORMATION</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>(a) Name of exempt principal trader:</span></p></td><td><p class=\"\"><span>BNP Paribas Financial Markets</span></p></td></tr><tr><td><p class=\"\"><span>(b) Name of offeror/offeree in relation to whose relevant securities this form relates:</span></p><p class=\"\"><span>     Use a separate form for each offeror/offeree</span></p></td><td><p class=\"\"><span>Beazley Plc</span></p></td></tr><tr><td><p class=\"\"><span>(c) Name of the party to the offer with which exempt principal trader is connected:</span></p></td><td><p class=\"\"><span>Connected to offeror 'Zurich Insurance Group'</span></p></td></tr><tr><td><p class=\"\"><span>(d) Date dealing undertaken:</span></p></td><td><p class=\"\"><span>25/02/2026</span></p></td></tr><tr><td><p class=\"\"><span>(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?</span></p><p class=\"\"><span>     If it is a cash offer or possible cash offer, state \"N/A\"</span></p></td><td><p class=\"\"><span>No</span></p><p class=\"\"><span>If YES, specify which:</span></p></td></tr></tbody></table></div><p class=\"\"><span>2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER</span></p><p class=\"\"><span>Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.</span></p><p class=\"\"><span>The currency of all prices and other monetary amounts should be stated.</span></p><p class=\"\"><span>(a)        Purchases and sales</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>Class of relevant security</span></p></td><td><p class=\"\"><span>Purchases/ sales</span></p></td><td><p class=\"\"><span>Total number of securities</span></p></td><td><p class=\"\"><span>Highest price per unit paid/received</span></p></td><td><p class=\"\"><span>Lowest price per unit paid/received</span></p></td></tr><tr><td><p class=\"\"><span>GB00BYQ0JC66</span></p></td><td><p class=\"\"><span>Purchase</span></p></td><td><p class=\"\"><span>605,829</span></p></td><td><p class=\"\"><span>12.4400 GBP</span></p></td><td><p class=\"\"><span>12.3000 GBP</span></p></td></tr><tr><td><p class=\"\"><span>GB00BYQ0JC66</span></p></td><td><p class=\"\"><span>Sale</span></p></td><td><p class=\"\"><span>-1,346,033</span></p></td><td><p class=\"\"><span>12.4400 GBP</span></p></td><td><p class=\"\"><span>12.2600 GBP</span></p></td></tr></tbody></table></div><p class=\"\"><span>(b)        Cash-settled derivative transactions</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Class of relevant security</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Product description</span></p><p class=\"\"><span>e.g. CFD</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Nature of dealing</span></p><p class=\"\"><span>e.g. opening/closing a long/short position, increasing/reducing a long/short position</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Number of reference securities</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Price per unit</span></p></li></ul><p class=\"\"><span>(c)        Stock-settled derivative transactions (including options)</span></p><p class=\"\"><span>(i)         Writing, selling, purchasing or varying</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Class of relevant security</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Product description e.g. call option</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Writing, purchasing, selling, varying etc.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Number of securities to which option relates</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Exercise price per unit</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Type</span></p><p class=\"\"><span>e.g. American, European etc.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Expiry date</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Option money paid/ received per unit</span></p></li></ul><p class=\"\"><span>(ii)        Exercise</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Class of relevant security</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Product description</span></p><p class=\"\"><span>e.g. call option</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Exercising/ exercised against</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Number of securities</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Exercise price per unit</span></p></li></ul><p class=\"\"><span>(d)        Other dealings (including subscribing for new securities)</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Class of relevant security</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Nature of dealing</span></p><p class=\"\"><span>e.g. subscription, conversion</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Details</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Price per unit (if applicable)</span></p></li></ul><p class=\"\"><span>3.         OTHER INFORMATION</span></p><p class=\"\"><span>(a)        Indemnity and other dealing arrangements</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:</span></p><p class=\"\"><span>Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state \"none\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>None</span></p></li></ul><p class=\"\"><span>(b)        Agreements, arrangements or understandings relating to options or derivatives</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:</span></p><p class=\"\"><span>(i)  the voting rights of any relevant securities under any option; or</span></p><p class=\"\"><span>(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:</span></p><p class=\"\"><span>If there are no such agreements, arrangements or understandings, state \"none\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>None</span></p></li></ul><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><span>Date of disclosure:</span></td><td><p class=\"\"><span>26/02/2026</span></p></td></tr><tr><td><span>Contact name:</span></td><td><p class=\"\"><span>Compliance Control Room</span></p></td></tr><tr><td><span>Telephone number:</span></td><td><p class=\"\"><span>0207 595 9695</span></p></td></tr></tbody></table></div><p class=\"\"><span>Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. </span></p><p class=\"\"><span>The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.</span></p><p class=\"\"><span>The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.</span></p><span>This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.</span><p class=\"\"><span>RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END  FERKZGZZGVMGVZM</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026-02-26:newsml_RSZ5601Ua:0-reg-bnp-paribas-london-beazley-plc-form-8-5-ept-ri-beazley-plc-bnpp-financial-mkts/",
            "pub_date": "2026-02-26 18:52:46",
            "source": "London Stock Exchange",
            "kind": 1,
            "language": "en"
        }
    ]
}